PRESS RELEASE: IVI Research Brief Discusses Limitations of ICER’s Analysis for JAK Inhibitors
As part of its Value Blueprints series, IVI’s latest research brief grapples with a question prompted by ICER’s recent assessment of RA therapies: Do conventional value assessments address the questions most relevant to real-world decisions about treatment pathways for chronic diseases? In the brief, the authors discuss how the failure of ICER’s analysis to evaluate […]
PRESS RELEASE: IVI’s Updated RA Model Examines New Treatment Options, Treatment Effects and Cost Estimates
IVI has just released the latest update to the organization’s Rheumatoid Arthritis (RA) Value Assessment Model. The updated model now incorporates additional treatment options (triple therapy, Janus Kinase (JAK) inhibitors, sarilumab, and biosimilars), updated treatment effect estimates based on additional randomized controlled trial (RCT) evidence, and updated cost estimates. The model is also designed to […]
PRESS RELEASE: IVI Announces Six New Members to Board of Directors
IVI is pleased to announce the latest additions to our diverse and growing Board of Directors. Read the full press release here to learn who is helping us drive value assessment to the next level in 2020.
PRESS RELEASE: Dr. Patricia Deverka Appointed as IVI’s First Chief Science Officer
IVI is thrilled to announce Pat Deverka, MD has joined our organization as our first Chief Science Officer. Dr. Deverka. Dr. Deverka brings to IVI more than three decades of experience in health economic research, public policy, patient engagement and program measurement across several academic, corporate and non-profit institutions. Read the full press release here […]
PRESS RELEASE: IVI Convenes First-of-its-Kind Multi-Stakeholder Summit to Accelerate Aligning Value Assessment Methods with Real-World Decision Needs
Participants Define Consensus Expectations and Prioritize Research Agenda to Improve Value Assessment Methods Alexandria, VA – March 17, 2020 – The Innovation and Value Initiative (IVI), a research-based non-profit improving the science and practice of value assessment, recently hosted a first-of-its-kind multi-stakeholder summit to examine current gaps and emerging approaches in value assessment. The program […]
PRESS RELEASE: Seven High-Profile Patient Engagement Leaders to Advise Nonprofit on its Patient-Focused Research Agenda
Alexandria, VA – May 6, 2020 – The Innovation and Value Initiative (IVI), a research-based non-profit improving the science and practice of value assessment, today announced the appointment of seven members to its Patient Advisory Council, and advisory body designed to ensure the patient always remains at the forefront of value assessment. The Council, which […]
PRESS RELEASE: IVI Announces Grant to National Health Council, National Alliance of Healthcare Purchaser Coalitions to Improve Value Assessment
Goal: Identify Areas of Consensus to Ultimately Make the Value Assessment Process Useful to Those Who Receive and Pay for Care Alexandria, VA – July 20, 2020 – The Innovation and Value Initiative (IVI), a non-profit research organization dedicated to improving the science and practice of value assessment, announced today it is awarding a grant […]
PRESS RELEASE: IVI’s Next Value Assessment Model to Address Major Depressive Disorder Interventions
First of Its Kind Depression Model to be Informed by Input from Diverse Advisory Group September 9, 2020 — Alexandria, VA — The Innovation and Value Initiative (IVI) — a non-profit organization dedicated to advancing the science, practice, and use of value assessment in healthcare — today announced a multi-year initiative to build and test […]
PRESS RELEASE: IVI Selects Pharmerit to Construct Foundation of Major Depressive Disorder Value Assessment Model
Health Economics Experts to Work with IVI-convened Advisory Group to Assess and Determine Model Inputs October 20, 2020 — Alexandria, VA — The Innovation and Value Initiative (IVI)— a nonprofit organization dedicated to advancing the science, practice, and use of value assessment in healthcare—today announced it has selected Pharmerit – an OPEN Health Company, as […]
PRESS RELEASE: IVI Research Brief Examines Value Assessment in the Age of COVID
Researchers Highlight Important Advancements in Understanding Value Emerging from the Pandemic Alexandria, VA — November 10, 2020 — The Innovation and Value Initiative (IVI) — a nonprofit organization dedicated to advancing the science, practice, and use of value assessment in healthcare — today released its latest Value Blueprints research brief recommending key areas for adapting […]